PHASE II STUDY OF 9-AMINOCAMPTOTHECIN (9-AC/DMA, NSC 603071) IN PREVIOUSLY TREATED HODGKIN'S DISEASE AND NON-HODGKIN'S LYMPHOMA: IWF GRADES A-H.
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2013
At a glance
- Drugs IDEC 132 (Primary)
- Indications Hodgkin's disease; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 26 Nov 2008 Status changed from active, no longer recruiting to completed, based on information from ClinicalTrials.gov.
- 11 Oct 2005 New trial record.